YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Photo by geralt on Pixabay Moderna's commercial business has shrunk and is lossmaking, which puts the weight of its market value on a pipeline rather than on revenue. Moderna (MRNA) has returned about 486% over the trailing twelve months,…
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Apnimed (NasdaqGS:APMD) has been added to the NASDAQ Composite Index, increasing its visibility among index-following investors. In…
Stock market leaders are becoming plentiful as the S&P 500 probes all-time highs. Recent IPO Bending Spoons clears an IPO base. Continue Reading
CAMBRIDGE, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed”), a late stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address t…
(Bloomberg) -- Apnimed Inc., a late-stage drug developer focused on sleep apnea rose 6.3% on Friday after raising $192 million in an upsized US initial public offering. Most Read from Bloomberg Singapore's Gated Island for the Rich Is Marr…
(RTTNews) - Apnimed, Inc. (APMD), a late-stage clinical pharmaceutical company, announced the pricing of 12 million shares at a price to the public of $16.00 per share, with gross proceeds expected to be approximately $192 million before u…
[IPO Concept with Stock Market Graphs] * Apnimed (APMD [https://seekingalpha.com/symbol/APMD]) priced [https://seekingalpha.com/pr/20602508-apnimed-announces-pricing-of-upsized-initial-public-offering] its upsized IPO of 12M shares at $16.…
Apnimed is eyeing a spot on the Nasdaq exchange through an IPO worth up to $160m, which will support the company as it looks to debut its potentially "best-in-class" therapy on the US obstructive sleep apnoea (OSA) market. Through its publ…